The drugmaker stopped paying 340B discounts to hospitals that didn’t comply with its new paperwork requirements late last ...

Long-term 340B participation is linked to stronger financial assets, with much of the program’s recent growth flowing ...

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...

A judge on Tuesday rejected a challenge from major pharmaceutical companies against Washington’s new law trying to reduce ...

Amid barbs over the shutdown and broader healthcare funding cuts, a Thursday committee hearing brought bipartisan agreement that more can be done to ensure the pricey drug subsidy program remains a ...

Established under the Public Health Service Act in 1992, the 340B drug pricing program has a critical goal: improve access to medicines for low-income patients at qualifying hospitals and clinics.

The Health Resources and Services Administration ("HRSA") plans to implement a limited pilot program that will allow approved manufacturers to issue post-purchase rebates for 340B covered outpatient ...

Careful analysis of the seemingly intractable problem of rising medical costs can typically be reduced to three things: 1) ...

Illinois lawmakers passed two bills balancing hospital protections and audits for the federal 340B drug program.

The 340B program was originally designed to assist hospitals that treat under- or uninsured patients in receiving discounted pharmaceutical drugs. Now, the federal subsidy program is getting a second ...